News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–84
- Matches
- 84
- Sources here
- 6
- Companies here
- 4
Search results
Stored financial headlines
Active search
84 matching headlines
Ticker or company: CVSMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Swiss National Bank Has $267.56 Million Holdings in CVS Health Corporation $CVS
The Swiss National Bank increased its stake in CVS Health Corporation by 7.2% in Q1, bringing its total holdings to 3.73 million shares valued at approximately $267.6 million. This comes as CVS reported strong quarterly results, beating revenue and EPS estimates, and issued a …
CVS
main company
Sharemaestro market context
Trend signal active
52 weeks +39.7%
CVS Health Corporation $CVS Shares Acquired by AIA Group Ltd
AIA Group Ltd significantly increased its stake in CVS Health Corporation by 104.8% in the first quarter, now owning 177,654 shares valued at $12.76 million. Other institutional investors also adjusted their positions in CVS Health, with hedge funds and institutional investors collectively owning 80.66% …
CVS
main company
Sharemaestro market context
Trend signal active
52 weeks +39.7%
CVS Caremark Mail Service Pharmacy by CVS Health Corp. - steady B2B engine for prescriptions
The article describes CVS Caremark Mail Service Pharmacy as a crucial business-to-business (B2B) engine for CVS Health Corp., handling millions of maintenance prescriptions primarily for employers and health plans in the United States. This service focuses on high-volume, automated mail dispensing of medications, aiming …
CVS
main company
Sharemaestro market context
Trend signal active
52 weeks +39.7%
CVS Health (CVS) Stock Looks Pricey On FTC Insulin Settlement
CVS Health's stock has seen a significant increase over the past year, returning 74.4%. However, its current valuation, with a P/E ratio of 46.3x, is considered expensive compared to the Healthcare industry average of 25.5x and a fair P/E of 40.7x. The article suggests …
CVS
main company
Sharemaestro market context
Trend signal active
52 weeks +39.7%
CVS Health (NYSE:CVS) Stock Rating Lowered by Wall Street Zen
Wall Street Zen has downgraded CVS Health (NYSE:CVS) from "buy" to "hold," despite other analysts raising price targets and a generally positive outlook from a broader analyst pool. CVS Health reported strong quarterly results, exceeding both earnings and revenue expectations, but faces ongoing regulatory …
Sharemaestro market context Trend signal active 52 weeks +39.7%CVS stalls just under its 52-week high while Healthcare Plans breadth does the heavy lifting
CVS Health closed at $104.2, only 1.9% below its 52-week peak, but the latest weekly move lacked volume confirmation and relative strength has cooled over four weeks.
CVS
main company
Sharemaestro market context
Trend signal active
52 weeks +39.7%
CVS reaches the top of its yearly range as managed-care breadth outpaces broader Healthcare
CVS Health finished the week at $102.00, only 0.8% below its 52-week high, with an active Trend Signal and stronger industry backing than the wider Healthcare sector.
CVS
main company
Sharemaestro market context
Trend signal active
52 weeks +39.7%